John Hellstein, DDS, MS

 John Hellstein, DDS, MS

John Hellstein, DDS, MS 

Saturday, April 9, 2011
1. 8 – 9:30 am
2. 10 – 11:30 am
1.5 CE Credits Each
3. 1:30 - 4:30 pm 
3 CE Credits 
All Courses Recommended for: Dentists, Hygienists, Assistants
ODA courses



1. Case Presentations of Bisphosphonate Osteonecrosis of the Jaws

As etiology of bisphosphonate osteonecrosis of the jaw has become familiar to practitioners this course will focus mostly on presentation of actual cases and how they were or are being managed. Audience participation about real world scenarios will be encouraged and important current literature will be updated

Following this course participants will be able to identify products associated with bisphosphonate osteonecrosis of the jaws. Products discussed will include:

  • Zometa® (zoledronic acid)
  • Aredia® (pamidronate)
  • Fosamax® (alendronate)
  • Actonel® (risedronate)
  • Boniva®. (ibandronate)
  • Reclast®.(zoledronic acid)
  • Prolia® (denosumab)

Participants will recognize the different risk factors associated with the IV versions of these medications as well as the oral versions of the medications. Participants will be better able to apply proper preventive techniques to avoid osteonecrosis of the jaw and decide treatment protocols for their patients.

2. Burning Mouth Syndrome and the Chronic Pain Patient

This course will cover the management of common mucositis with particular emphasis on the burning mouth syndrome.

At the conclusion of this course, attendees will be able to analyze the potential factors associated with non-specific mucositis and in particular patients with essentially normal clinical findings. Management strategies will be emphasized. A better understanding of symptomatic geographic tongue will also be possible.

 3. Common Therapeutic Regimens for Common Mucosal Diseases

This course with a mid-point break will cover common oral lesions and how to manage them in a general dentistry setting.

Following this course, clinicians will be able to recognize and choose the most appropriate therapy for their patients.

Diseases to be covered include:

  • Primary herpetic gingival stomatitis
  • Aphthous stomatitis
  • Common irritations secondary to dental healthcare products
  • Pyogenic granuloma
  • Peripheral ossifying fibroma
  • Angular cheilitis  

John Hellstein, DDS, MS graduated from the UMKC Dental School in 1982. He received an M.S. in Stomatology and a Certificate in Oral Pathology from the Iowa in 1991. Since 2002, he has been appointed Clinical Professor at Iowa. Current interest has centered on osteochemonecrosis of the jaws and is currently Chair of the Advisory Committee on anti-resorptive therapeutic agents. He has written multiple articles on the subject as well. Recent book chapters have centered on vesiculo-ulcerative diseases of the oral cavity as well as odontogenic cysts and tumors. His past and present professional positions include: Chair and Vice-chair ADA Council on Scientific Affairs, Director of Education of the AAOMP, Director of American Board of Oral and Maxillofacial Pathology, Secretary, Chair-elect and Chair, Oral and Maxillofacial Pathology Section, American Dental Educators Association; and Medical Advisory Board for the Basal Cell Carcinoma Nevus Syndrome Organization.